Global Standardized Financials

230.62 0.58(0.25%)05/17/2024
Biogen Inc (BIIB)

Income Statement
(Values in USD Thousands)
 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Income393,400-68,100591,600387,900
Revenue2,200,3002,530,3002,456,0002,463,000
Cost Of Revenue689,800659,600592,700662,800
gross Profit1,510,5001,870,7001,863,3001,800,200
Operating Expenses965,1001,635,9001,242,0001,282,900
Selling General and Administrative Expenses581,500788,200548,000605,000
Research and Development Expenses383,600736,300584,200570,600
Other Expenses-1,900-300,000109,800107,300
Cost And Expenses1,654,9002,295,5001,834,7001,945,700
Operating Income545,400-141,200655,700526,900
Interest Income17,40095,90075,90080,900
Income Tax Expense71,400-72,900114,80050,700
Income Before Tax464,800-141,200708,100438,300
Earning Per Share Basic2.71-0.474.092.69
Earning Per Share Diluted2.70-0.474.072.67
weighted Average Shares Outstanding145,200144,800144,700144,400
weighted Average Shares Outstanding (Diluted)145,900144,800145,500145,200
Gross Margin0.690.740.760.73
EBIT Margin0.310.150.290.23
Profit Margin0.18-0.030.240.16
EBITDA693,000371,700708,600577,100
Earning Before Tax Margin0.21-0.060.290.18